How long-read sequencing is scaling beyond the specialist lab
Here, Aaron Wenger, Principal Scientist – Bioinformatics at PacBio (CA, USA), explores how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale. Advances in genomic sequencing have led to significant gains in our understanding of human, plant,...
The most detailed map yet of the maternal–fetal connection
Advanced single-cell and spatial methods reveal the maternal–fetal connection in unprecedented detail. Researchers from University of California San Francisco (UCSF; CA, USA) have investigated the human maternal–fetal interface (MFI), constructing the most comprehensive cell atlas of the...
What Are Security Experts Saying About Claude Mythos and Project Glasswing?
Security experts share their thoughts on Claude Mythos and Project Glasswing with Security magazine. Continue reading →
Top Secret Clearance Holder Charged With Leaking Classified National Defense Information
Former Army employee indicted for allegedly sharing classified national defense information to unauthorized individuals. Continue reading →
School’s Out, But Security’s Not: Preparing for K-12 Summertime Security
To best prepare for the summer months, school security leaders must understand how the threats they face change once the school year ends. Continue reading →
RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders
The newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety. Elsewhere, Gilead licensed a Kymera drug and a new RNA-focused startup emerged. Continue reading →
FDA again spurns Replimune melanoma drug
The decision, which has been a flashpoint in an ongoing debate about regulatory flexibility, was made because Replimune failed to address the agency's issues with the drug's study results, the FDA said. Continue reading →
Oricell closes a ‘pre-IPO’ megaround to aim CAR-T at solid tumors
The Shanghai-based biotech has a cell therapy that, if successful in testing, could become the first treatment of its kind for liver cancer. Continue reading →